<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM"><PMID Version="1">32764283</PMID><DateCompleted><Year>2021</Year><Month>02</Month><Day>17</Day></DateCompleted><DateRevised><Year>2021</Year><Month>02</Month><Day>17</Day></DateRevised><Article PubModel="Electronic"><Journal><ISSN IssnType="Electronic">1422-0067</ISSN><JournalIssue CitedMedium="Internet"><Volume>21</Volume><Issue>16</Issue><PubDate><Year>2020</Year><Month>Aug</Month><Day>05</Day></PubDate></JournalIssue><Title>International journal of molecular sciences</Title><ISOAbbreviation>Int J Mol Sci</ISOAbbreviation></Journal><ArticleTitle>Inclusion Formation and Toxicity of the ALS Protein RGNEF and Its Association with the Microtubule Network.</ArticleTitle><ELocationID EIdType="pii" ValidYN="Y">5597</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3390/ijms21165597</ELocationID><Abstract><AbstractText>The Rho guanine nucleotide exchange factor (RGNEF) protein encoded by the <i>ARHGEF28</i> gene has been implicated in the neurodegenerative disease amyotrophic lateral sclerosis (ALS). Biochemical and pathological studies have shown that RGNEF is a component of the hallmark neuronal cytoplasmic inclusions in ALS-affected neurons. Additionally, a heterozygous mutation in <i>ARHGEF28</i> has been identified in a number of familial ALS (fALS) cases that may give rise to one of two truncated variants of the protein. Little is known about the normal biological function of RGNEF or how it contributes to ALS pathogenesis. To further explore RGNEF biology we have established and characterized a yeast model and characterized RGNEF expression in several mammalian cell lines. We demonstrate that RGNEF is toxic when overexpressed and forms inclusions. We also found that the fALS-associated mutation in <i>ARGHEF28</i> gives rise to an inclusion-forming and toxic protein. Additionally, through unbiased screening using the split-ubiquitin system, we have identified RGNEF-interacting proteins, including two ALS-associated proteins. Functional characterization of other RGNEF interactors identified in our screen suggest that RGNEF functions as a microtubule regulator. Our findings indicate that RGNEF misfolding and toxicity may cause impairment of the microtubule network and contribute to ALS pathogenesis.</AbstractText></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Di Gregorio</LastName><ForeName>Sonja E</ForeName><Initials>SE</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Western Ontario, London, ON N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Volkening</LastName><ForeName>Kathryn</ForeName><Initials>K</Initials><Identifier Source="ORCID">0000-0002-7601-4869</Identifier><AffiliationInfo><Affiliation>Clinical Neurological Sciences, University of Western Ontario, London, ON N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Strong</LastName><ForeName>Michael J</ForeName><Initials>MJ</Initials><AffiliationInfo><Affiliation>Clinical Neurological Sciences, University of Western Ontario, London, ON N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Duennwald</LastName><ForeName>Martin L</ForeName><Initials>ML</Initials><AffiliationInfo><Affiliation>Department of Pathology and Laboratory Medicine, University of Western Ontario, London, ON N6A 5C1, Canada.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>Bernice Ramsey, Trainee Scholarship</GrantID><Agency>ALS Society of Canada</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2020</Year><Month>08</Month><Day>05</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Int J Mol Sci</MedlineTA><NlmUniqueID>101092791</NlmUniqueID><ISSNLinking>1422-0067</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="C551174">ARHGEF28 protein, human</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D020662">Guanine Nucleotide Exchange Factors</NameOfSubstance></Chemical><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D025801">Ubiquitin</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D000690" MajorTopicYN="N">Amyotrophic Lateral Sclerosis</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D000818" MajorTopicYN="N">Animals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D005786" MajorTopicYN="N">Gene Expression Regulation</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D020662" MajorTopicYN="N">Guanine Nucleotide Exchange Factors</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006579" MajorTopicYN="N">Heterozygote</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008322" MajorTopicYN="N">Mammals</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008870" MajorTopicYN="N">Microtubules</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D009154" MajorTopicYN="N">Mutation</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D009474" MajorTopicYN="N">Neurons</DescriptorName><QualifierName UI="Q000378" MajorTopicYN="Y">metabolism</QualifierName><QualifierName UI="Q000473" MajorTopicYN="N">pathology</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D011485" MajorTopicYN="N">Protein Binding</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D025801" MajorTopicYN="N">Ubiquitin</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D015003" MajorTopicYN="N">Yeasts</DescriptorName><QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">ALS</Keyword><Keyword MajorTopicYN="N">RGNEF</Keyword><Keyword MajorTopicYN="N">microtubules</Keyword><Keyword MajorTopicYN="N">neurodegeneration</Keyword><Keyword MajorTopicYN="N">protein misfolding</Keyword><Keyword MajorTopicYN="N">yeast model</Keyword></KeywordList><CoiStatement>The authors declare no conflict of interest.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2020</Year><Month>6</Month><Day>25</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2020</Year><Month>7</Month><Day>15</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2020</Year><Month>7</Month><Day>31</Day></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2020</Year><Month>8</Month><Day>9</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2021</Year><Month>2</Month><Day>18</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">32764283</ArticleId><ArticleId IdType="pmc">PMC7460592</ArticleId><ArticleId IdType="doi">10.3390/ijms21165597</ArticleId><ArticleId IdType="pii">ijms21165597</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Hardiman O., Chalabi A., Chio A., Corr M.E., Logroscino G., Robberecht W., Shaw P.J., Simmons Z., Van Den Berg H.L. Amyotrophic lateral sclerosis. Nat. Rev. Dis. Primers. 2017;3:17071. doi: 10.1038/nrdp.2017.71.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrdp.2017.71</ArticleId><ArticleId IdType="pubmed">28980624</ArticleId></ArticleIdList></Reference><Reference><Citation>Chen S., Sayana P., Zhang X., Le W. Genetics of amyotrophic lateral sclerosis: An update. Mol. Neurodegener. 2013;8:28. doi: 10.1186/1750-1326-8-28.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1750-1326-8-28</ArticleId><ArticleId IdType="pmc">PMC3766231</ArticleId><ArticleId IdType="pubmed">23941283</ArticleId></ArticleIdList></Reference><Reference><Citation>Srinivasan E., Rajasekaran R. A Systematic and Comprehensive Review on Disease-Causing Genes in Amyotrophic Lateral Sclerosis. J. Mol. Neurosci. 2020 doi: 10.1007/s12031-020-01569-w.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s12031-020-01569-w</ArticleId><ArticleId IdType="pubmed">32415434</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Fryer J.D. A matter of balance. eLife. 2018;7:e40034. doi: 10.7554/eLife.40034.</Citation><ArticleIdList><ArticleId IdType="doi">10.7554/eLife.40034</ArticleId><ArticleId IdType="pmc">PMC6103765</ArticleId><ArticleId IdType="pubmed">30129439</ArticleId></ArticleIdList></Reference><Reference><Citation>Parakh S., Atkin J.D. Protein folding alterations in amyotrophic lateral sclerosis. Brain Res. 2016;1648:633&#x2013;649. doi: 10.1016/j.brainres.2016.04.010.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.brainres.2016.04.010</ArticleId><ArticleId IdType="pubmed">27064076</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C., Estrada L.D. Protein misfolding and neurodegeneration. Arch. Neurol. 2008;65:184&#x2013;189. doi: 10.1001/archneurol.2007.56.</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/archneurol.2007.56</ArticleId><ArticleId IdType="pubmed">18268186</ArticleId></ArticleIdList></Reference><Reference><Citation>Soto C. Unfolding the role of protein misfolding in neurodegenerative diseases. Nat. Rev. Neurosci. 2003;4:49&#x2013;60. doi: 10.1038/nrn1007.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nrn1007</ArticleId><ArticleId IdType="pubmed">12511861</ArticleId></ArticleIdList></Reference><Reference><Citation>Saberi S., Stauffer J.E., Schulte D.J., Ravits J. Neuropathology of Amyotrophic Lateral Sclerosis and Its Variants. Neurol. Clin. 2015;33:855&#x2013;876. doi: 10.1016/j.ncl.2015.07.012.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ncl.2015.07.012</ArticleId><ArticleId IdType="pmc">PMC4628785</ArticleId><ArticleId IdType="pubmed">26515626</ArticleId></ArticleIdList></Reference><Reference><Citation>Kryndushkin D., Shewmaker F. Modeling ALS and FTLD proteinopathies in yeast: An efficient approach for studying protein aggregation and toxicity. Prion. 2011;5:250&#x2013;257. doi: 10.4161/pri.17229.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.17229</ArticleId><ArticleId IdType="pmc">PMC4012400</ArticleId><ArticleId IdType="pubmed">22052354</ArticleId></ArticleIdList></Reference><Reference><Citation>Redler R.L., Dokholyan N.V. The complex molecular biology of amyotrophic lateral sclerosis (ALS) Prog. Mol. Biol. Transl. Sci. 2012;107:215&#x2013;262.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3605887</ArticleId><ArticleId IdType="pubmed">22482452</ArticleId></ArticleIdList></Reference><Reference><Citation>Patel A., Lee H.O., Jawerth L., Drechsel D., Hyman A.A. A Liquid-to-Solid Phase Transition of the ALS Protein FUS Accelerated by Disease Mutation. Cell. 2015;162:1066&#x2013;1077. doi: 10.1016/j.cell.2015.07.047.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2015.07.047</ArticleId><ArticleId IdType="pubmed">26317470</ArticleId></ArticleIdList></Reference><Reference><Citation>Cannon J.R., Greenamyre J.T. The role of environmental exposures in neurodegeneration and neurodegenerative diseases. Toxicol. Sci. 2011;124:225&#x2013;250. doi: 10.1093/toxsci/kfr239.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/toxsci/kfr239</ArticleId><ArticleId IdType="pmc">PMC3216414</ArticleId><ArticleId IdType="pubmed">21914720</ArticleId></ArticleIdList></Reference><Reference><Citation>Barber S.C., Mead R.J., Shaw P.J. Oxidative stress in ALS: A mechanism of neurodegeneration and a therapeutic target. Biochim. Biophys. Acta. 2006;1762:1051&#x2013;1067. doi: 10.1016/j.bbadis.2006.03.008.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.bbadis.2006.03.008</ArticleId><ArticleId IdType="pubmed">16713195</ArticleId></ArticleIdList></Reference><Reference><Citation>Kikis E.A., Gidalevitz T., Morimoto R.I. Protein homeostasis in models of aging and age-related conformational disease. Adv. Exp. Med. Biol. 2010;694:138&#x2013;159.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC3402352</ArticleId><ArticleId IdType="pubmed">20886762</ArticleId></ArticleIdList></Reference><Reference><Citation>Volkening K., Leystra-Lantz C., Strong M.J. Human low molecular weight neurofilament (NFL) mRNA interacts with a predicted p190 RhoGEF homologue (RGNEF) in humans. Amyotroph. Lateral Scler. 2010;11:97&#x2013;103. doi: 10.3109/17482960902995584.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/17482960902995584</ArticleId><ArticleId IdType="pubmed">19488899</ArticleId></ArticleIdList></Reference><Reference><Citation>Keller B.A., Volkening K., Droppelmann C.A., Ang L.C., Rademakers R., Strong M.J. Co-aggregation of RNA binding proteins in ALS spinal motor neurons: Evidence of a common pathogenic mechanism. Acta Neuropathol. 2012;124:733&#x2013;747. doi: 10.1007/s00401-012-1035-z.</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00401-012-1035-z</ArticleId><ArticleId IdType="pubmed">22941224</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann C., Wang J., Campos-Melo D., Keller B., Volkening K., Hegele R.A., Strong M.J. Detection of a novel frameshift mutation and regions with homozygosis within ARHGEF28 gene in familial amyotrophic lateral sclerosis. Amyotroph. Lateral Scler. Front. Degener. 2013;14:444&#x2013;451. doi: 10.3109/21678421.2012.758288.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2012.758288</ArticleId><ArticleId IdType="pubmed">23286752</ArticleId></ArticleIdList></Reference><Reference><Citation>Tavolieri M.V., Droppelmann C.A., Campos-Melo D., Volkening K., Strong M.J. A novel overlapping NLS/NES region within the PH domain of Rho Guanine Nucleotide Exchange Factor (RGNEF) regulates its nuclear-cytoplasmic localization. Eur. J. Cell Biol. 2019;98:27&#x2013;35. doi: 10.1016/j.ejcb.2018.11.001.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.ejcb.2018.11.001</ArticleId><ArticleId IdType="pubmed">30482479</ArticleId></ArticleIdList></Reference><Reference><Citation>Kleinschmidt E.G., Miller N.L.G., Ozmadenci D., Tancioni I., Osterman C.D., Barrie A.M., Taylor C.N., Ye A., Jiang S., Connolly D.C., et al. Rgnef promotes ovarian tumor progression and confers protection from oxidative stress. Oncogene. 2019;38:6323&#x2013;6337. doi: 10.1038/s41388-019-0881-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41388-019-0881-8</ArticleId><ArticleId IdType="pmc">PMC7252434</ArticleId><ArticleId IdType="pubmed">31308489</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheung K., Droppelmann C.A., MacLellan A., Cameron A., Withers B., Campos-Melo D., Volkening K., Strong M.J. Rho guanine nucleotide exchange factor (RGNEF) is a prosurvival factor under stress conditions. Mol. Cell. Neurosci. 2017;82:88&#x2013;95. doi: 10.1016/j.mcn.2017.05.003.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.mcn.2017.05.003</ArticleId><ArticleId IdType="pubmed">28495450</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu J., Zhai J., Lin H., Nie Z., Ge W.W., Garcia-Bermejo L., Muschel R.J., Schlaepfer W.W., Canete-Soler R. Cytoplasmic retention sites in p190 RhoGEF confer anti-apoptotic activity to an EGFP-tagged protein. Brain Res. Mol. Brain Res. 2003;117:27&#x2013;38. doi: 10.1016/S0169-328X(03)00263-8.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0169-328X(03)00263-8</ArticleId><ArticleId IdType="pubmed">14499478</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller N.L., Lawson C., Chen X.L., Lim S.T., Schlaepfer D.D. Rgnef (p190 RhoGEF) knockout inhibits RhoA activity, focal adhesion establishment, and cell motility downstream of integrins. PLoS ONE. 2012;7:e37830. doi: 10.1371/journal.pone.0037830.</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0037830</ArticleId><ArticleId IdType="pmc">PMC3359313</ArticleId><ArticleId IdType="pubmed">22649559</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu H.G., Nam J.O., Miller N.L., Tanjoni I., Walsh C., Shi L., Kim L., Chen X.L., Tomar A., Lim S.T., et al. RhoGEF (Rgnef) promotes colon carcinoma tumor progression via interaction with focal adhesion kinase. Cancer Res. 2011;71:360&#x2013;370. doi: 10.1158/0008-5472.CAN-10-2894.</Citation><ArticleIdList><ArticleId IdType="doi">10.1158/0008-5472.CAN-10-2894</ArticleId><ArticleId IdType="pmc">PMC3064514</ArticleId><ArticleId IdType="pubmed">21224360</ArticleId></ArticleIdList></Reference><Reference><Citation>Ma Y., Tang L., Chen L., Zhang B., Deng P., Wang J., Yang Y., Liu R., Yang Y., Ye S., et al. ARHGEF28 gene exon 6/intron 6 junction mutations in Chinese amyotrophic lateral sclerosis cohort. Amyotroph. Lateral Scler. Front. Degener. 2014;15:309&#x2013;311. doi: 10.3109/21678421.2014.896926.</Citation><ArticleIdList><ArticleId IdType="doi">10.3109/21678421.2014.896926</ArticleId><ArticleId IdType="pubmed">24712971</ArticleId></ArticleIdList></Reference><Reference><Citation>Farhan S.M.K., Gendron T.F., Petrucelli L., Hegele R.A., Strong M.J. ARHGEF28 p.Lys280 Metfs40 Ter in an amyotrophic lateral sclerosis family with a C9 orf72 expansion. Neurol. Genet. 2017;3:e190. doi: 10.1212/NXG.0000000000000190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1212/NXG.0000000000000190</ArticleId><ArticleId IdType="pmc">PMC5616022</ArticleId><ArticleId IdType="pubmed">28971145</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann C.A., Keller B.A., Campos-Melo D., Volkening K., Strong M.J. Rho guanine nucleotide exchange factor is an NFL mRNA destabilizing factor that forms cytoplasmic inclusions in amyotrophic lateral sclerosis. Neurobiol. Aging. 2013;34:248&#x2013;262. doi: 10.1016/j.neurobiolaging.2012.06.021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neurobiolaging.2012.06.021</ArticleId><ArticleId IdType="pubmed">22835604</ArticleId></ArticleIdList></Reference><Reference><Citation>Schmid W. Chemical Mutagens. Springer; Boston, MA, USA: 1976. The micronucleus test for cytogenetic analysis; pp. 31&#x2013;53.</Citation></Reference><Reference><Citation>Kirsch-Volders M., Elhajouji A., Cundari E., Van Hummelen P. The in vitro micronucleus test: A multi-endpoint assay to detect simultaneously mitotic delay, apoptosis, chromosome breakage, chromosome loss and non-disjunction. Mutat. Res. 1997;392:19&#x2013;30. doi: 10.1016/S0165-1218(97)00042-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0165-1218(97)00042-6</ArticleId><ArticleId IdType="pubmed">9269328</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann C.A., Campos-Melo D., Moszczynski A.J., Amzil H., Strong M.J. TDP-43 aggregation inside micronuclei reveals a potential mechanism for protein inclusion formation in ALS. Sci. Rep. 2019;9:1&#x2013;13. doi: 10.1038/s41598-019-56483-y.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-019-56483-y</ArticleId><ArticleId IdType="pmc">PMC6934605</ArticleId><ArticleId IdType="pubmed">31882736</ArticleId></ArticleIdList></Reference><Reference><Citation>Johnsson N., Varshavsky A. Split ubiquitin as a sensor of protein interactions in vivo. Proc. Natl. Acad. Sci. USA. 1994;91:10340&#x2013;10344. doi: 10.1073/pnas.91.22.10340.</Citation><ArticleIdList><ArticleId IdType="doi">10.1073/pnas.91.22.10340</ArticleId><ArticleId IdType="pmc">PMC45015</ArticleId><ArticleId IdType="pubmed">7937952</ArticleId></ArticleIdList></Reference><Reference><Citation>Lehming N. Analysis of protein-protein proximities using the split-ubiquitin system. Brief Funct. Genomic. Proteomic. 2002;1:230&#x2013;238. doi: 10.1093/bfgp/1.3.230.</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bfgp/1.3.230</ArticleId><ArticleId IdType="pubmed">15239890</ArticleId></ArticleIdList></Reference><Reference><Citation>Muller J., Johnsson N. Split-ubiquitin and the split-protein sensors: Chessman for the endgame. Chembiochem. 2008;9:2029&#x2013;2038. doi: 10.1002/cbic.200800190.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/cbic.200800190</ArticleId><ArticleId IdType="pubmed">18677736</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Horck F.P., Ahmadian M.R., Haeusler L.C., Moolenaar W.H., Kranenburg O. Characterization of p190 RhoGEF, a RhoA-specific guanine nucleotide exchange factor that interacts with microtubules. J. Biol. Chem. 2001;276:4948&#x2013;4956. doi: 10.1074/jbc.M003839200.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M003839200</ArticleId><ArticleId IdType="pubmed">11058585</ArticleId></ArticleIdList></Reference><Reference><Citation>Miller R.K., Heller K.K., Fris&#xe8;n L., Wallack D.L., Loayza D., Gammie A.E., Rose M.D. The kinesin-related proteins, Kip2 p and Kip3 p, function differently in nuclear migration in yeast. Mol. Biol. Cell. 1998;9:2051&#x2013;2068. doi: 10.1091/mbc.9.8.2051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1091/mbc.9.8.2051</ArticleId><ArticleId IdType="pmc">PMC25458</ArticleId><ArticleId IdType="pubmed">9693366</ArticleId></ArticleIdList></Reference><Reference><Citation>Schuyler S.C., Liu J.Y., Pellman D. The molecular function of Ase1 p: Evidence for a MAP-dependent midzone-specific spindle matrix. Microtubule-associated proteins. J. Cell Biol. 2003;160:517&#x2013;528. doi: 10.1083/jcb.200210021.</Citation><ArticleIdList><ArticleId IdType="doi">10.1083/jcb.200210021</ArticleId><ArticleId IdType="pmc">PMC2173742</ArticleId><ArticleId IdType="pubmed">12591913</ArticleId></ArticleIdList></Reference><Reference><Citation>Allingham J.S., Sproul L.R., Rayment I., Gilbert S.P. Vik1 modulates microtubule-Kar3 interactions through a motor domain that lacks an active site. Cell. 2007;128:1161&#x2013;1172. doi: 10.1016/j.cell.2006.12.046.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2006.12.046</ArticleId><ArticleId IdType="pmc">PMC1987336</ArticleId><ArticleId IdType="pubmed">17382884</ArticleId></ArticleIdList></Reference><Reference><Citation>Zheng Y., Hart M.J., Shinjo K., Evans T., Bender A., Cerione R.A. Biochemical comparisons of the Saccharomyces cerevisiae Bem2 and Bem3 proteins. Delineation of a limit Cdc42 GTPase-activating protein domain. J. Biol. Chem. 1993;268:24629&#x2013;24634.</Citation><ArticleIdList><ArticleId IdType="pubmed">8227021</ArticleId></ArticleIdList></Reference><Reference><Citation>Leung Y.Y., Yao Hui L.L., Kraus V.B. Colchicine&#x2013;Update on mechanisms of action and therapeutic uses. Semin. Arthritis Rheum. 2015;45:341&#x2013;350. doi: 10.1016/j.semarthrit.2015.06.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2015.06.013</ArticleId><ArticleId IdType="pmc">PMC4656054</ArticleId><ArticleId IdType="pubmed">26228647</ArticleId></ArticleIdList></Reference><Reference><Citation>Hoebeke J., Van Nijen G., De Brabander M. Interaction of oncodazole (R 17934), a new antitumoral drug, with rat brain tubulin. Biochem. Biophys. Res. Commun. 1976;69:319&#x2013;324. doi: 10.1016/0006-291X(76)90524-6.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0006-291X(76)90524-6</ArticleId><ArticleId IdType="pubmed">1267789</ArticleId></ArticleIdList></Reference><Reference><Citation>Masia-Balague M., Izquierdo I., Garrido G., Cordom&#xed; A., P&#xe9;rez-Benito L., Miller N.L.G., Schlaepfer D.D., Gigoux V., Aragay A.M. Gastrin-stimulated Galpha13 Activation of Rgnef Protein (ArhGEF28) in DLD-1 Colon Carcinoma Cells. J. Biol. Chem. 2015;290:15197&#x2013;15209. doi: 10.1074/jbc.M114.628164.</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/jbc.M114.628164</ArticleId><ArticleId IdType="pmc">PMC4463461</ArticleId><ArticleId IdType="pubmed">25922072</ArticleId></ArticleIdList></Reference><Reference><Citation>Droppelmann C.A., Campos-Melo D., Volkening K., Strong M.J. The emerging role of guanine nucleotide exchange factors in ALS and other neurodegenerative diseases. Front Cell Neurosci. 2014;8:282. doi: 10.3389/fncel.2014.00282.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fncel.2014.00282</ArticleId><ArticleId IdType="pmc">PMC4159981</ArticleId><ArticleId IdType="pubmed">25309324</ArticleId></ArticleIdList></Reference><Reference><Citation>Balikova I., Devriendt K., Fryns J.P., Vermeesch J.R. FOXD1 Duplication Causes Branchial Defects and Interacts with the TFAP2 A Gene Implicated in the Branchio-Oculo-Facial Syndrome in Causing Eye Effects in Zebrafish. Mol. Syndr. 2010;1:255&#x2013;261. doi: 10.1159/000327707.</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000327707</ArticleId><ArticleId IdType="pmc">PMC3214949</ArticleId><ArticleId IdType="pubmed">22140378</ArticleId></ArticleIdList></Reference><Reference><Citation>Gitler A.D., Shorter J. RNA-binding proteins with prion-like domains in ALS and FTLD-U. Prion. 2011;5:179&#x2013;187. doi: 10.4161/pri.5.3.17230.</Citation><ArticleIdList><ArticleId IdType="doi">10.4161/pri.5.3.17230</ArticleId><ArticleId IdType="pmc">PMC3226045</ArticleId><ArticleId IdType="pubmed">21847013</ArticleId></ArticleIdList></Reference><Reference><Citation>Di Gregorio S.E., Duennwald M.L. ALS Yeast Models-Past Success Stories and New Opportunities. Front. Mol. Neurosci. 2018;11:394. doi: 10.3389/fnmol.2018.00394.</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fnmol.2018.00394</ArticleId><ArticleId IdType="pmc">PMC6218427</ArticleId><ArticleId IdType="pubmed">30425620</ArticleId></ArticleIdList></Reference><Reference><Citation>Van Ham T.J., Breitling R., Swertz M.A., Nollen E.A.A. Neurodegenerative diseases: Lessons from genome-wide screens in small model organisms. EMBO Mol. Med. 2009;1:360&#x2013;370. doi: 10.1002/emmm.200900051.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/emmm.200900051</ArticleId><ArticleId IdType="pmc">PMC3378155</ArticleId><ArticleId IdType="pubmed">20049741</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., Outeiro T.F. Simple is good: Yeast models of neurodegeneration. FEMS Yeast Res. 2010;10:970&#x2013;979. doi: 10.1111/j.1567-1364.2010.00649.x.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/j.1567-1364.2010.00649.x</ArticleId><ArticleId IdType="pubmed">20579105</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., Franssens V., Winderickx J., Outeiro T.F. Yeast models of Parkinson&#x2019;s disease-associated molecular pathologies. Curr. Opin. Genet. Dev. 2017;44:74&#x2013;83. doi: 10.1016/j.gde.2017.01.013.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.gde.2017.01.013</ArticleId><ArticleId IdType="pubmed">28232272</ArticleId></ArticleIdList></Reference><Reference><Citation>Tenreiro S., Munder M.C., Alberti S., Outeiro T.F. Harnessing the power of yeast to unravel the molecular basis of neurodegeneration. J. Neurochem. 2013;127:438&#x2013;452. doi: 10.1111/jnc.12271.</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/jnc.12271</ArticleId><ArticleId IdType="pubmed">23600759</ArticleId></ArticleIdList></Reference><Reference><Citation>Dreser A., Vollrath J.T., Sechi A., Johann S., Roos A., Yamoah A., Katona I., Bohlega S., Wiemuth D., Tian Y., et al. The ALS-linked E102 Q mutation in Sigma receptor-1 leads to ER stress-mediated defects in protein homeostasis and dysregulation of RNA-binding proteins. Cell Death Differ. 2017;24:1655&#x2013;1671. doi: 10.1038/cdd.2017.88.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/cdd.2017.88</ArticleId><ArticleId IdType="pmc">PMC5596426</ArticleId><ArticleId IdType="pubmed">28622300</ArticleId></ArticleIdList></Reference><Reference><Citation>Griffin J.W., Watson D.F. Axonal transport in neurological disease. Ann. Neurol. 1988;23:3&#x2013;13. doi: 10.1002/ana.410230103.</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/ana.410230103</ArticleId><ArticleId IdType="pubmed">3278671</ArticleId></ArticleIdList></Reference><Reference><Citation>Sleigh J.N., Rossor A.M., Fellows A.D., Tosolini A.P., Schiavo G. Axonal transport and neurological disease. Nat. Rev. Neurol. 2019;15:691&#x2013;703. doi: 10.1038/s41582-019-0257-2.</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41582-019-0257-2</ArticleId><ArticleId IdType="pubmed">31558780</ArticleId></ArticleIdList></Reference><Reference><Citation>Smith B.N., Ticozzi N., Fallini C., Gkazi A.S., Topp S., Kenna K.P., Scotter E.L., Kost J., Keagle P., Miller J.W., et al. Exome-wide rare variant analysis identifies TUBA4 A mutations associated with familial ALS. Neuron. 2014;84:324&#x2013;331. doi: 10.1016/j.neuron.2014.09.027.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.neuron.2014.09.027</ArticleId><ArticleId IdType="pmc">PMC4521390</ArticleId><ArticleId IdType="pubmed">25374358</ArticleId></ArticleIdList></Reference><Reference><Citation>Weinhandl K., Winkler M., Glieder A., Camattari A. Carbon source dependent promoters in yeasts. Microb. Cell Fact. 2014;13:5. doi: 10.1186/1475-2859-13-5.</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/1475-2859-13-5</ArticleId><ArticleId IdType="pmc">PMC3897899</ArticleId><ArticleId IdType="pubmed">24401081</ArticleId></ArticleIdList></Reference><Reference><Citation>Thomas B.J., Rothstein R. Elevated recombination rates in transcriptionally active DNA. Cell. 1989;56:619&#x2013;630. doi: 10.1016/0092-8674(89)90584-9.</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0092-8674(89)90584-9</ArticleId><ArticleId IdType="pubmed">2645056</ArticleId></ArticleIdList></Reference><Reference><Citation>Katzen F. Gateway((R)) recombinational cloning: A biological operating system. Expert Opin. Drug. Discov. 2007;2:571&#x2013;589. doi: 10.1517/17460441.2.4.571.</Citation><ArticleIdList><ArticleId IdType="doi">10.1517/17460441.2.4.571</ArticleId><ArticleId IdType="pubmed">23484762</ArticleId></ArticleIdList></Reference><Reference><Citation>Gietz R.D. Yeast transformation by the LiAc/SS carrier DNA/PEG method. Methods Mol. Biol. 2014;1163:33&#x2013;44.</Citation><ArticleIdList><ArticleId IdType="pubmed">24841298</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>